Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Clinical trial NCT04237740 · UNKNOWN
Trial details
- NCT number
- NCT04237740
- Sponsor
- RenJi Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2022-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.